Evidence map›Paper›PMID 32036090›Full record

ArticleThe Journal of molecular diagnostics : JMD2020

Highly Sensitive Blocker Displacement Amplification and Droplet Digital PCR Reveal Low-Level Parental FOXF1 Somatic Mosaicism in Families with Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins.

Justyna A Karolak, Qian Liu, Nina G Xie, Lucia R Wu, Gustavo Rocha, Susana Fernandes, Luk Ho-Ming, Ivan F Lo, David Mowat, Elizabeth K Fiorino and 9 more

Abstract read
In one paragraph

Article in The Journal of molecular diagnostics : JMD, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Justyna A KarolakDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas; Department of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, Poznan, Poland.
Qian LiuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
Nina G XieDepartment of Bioengineering, Rice University, Houston, Texas.
Lucia R WuDepartment of Bioengineering, Rice University, Houston, Texas.
Gustavo RochaDepartment of Neonatology, Centro Hospitalar Universitário de São João, Porto, Portugal.
Susana FernandesDepartment of Genetics, Faculty of Medicine, Porto University, Porto, Portugal; Institute of Research and Innovation in Health, Porto, Portugal.
Luk Ho-MingClinical Genetic Service, Department of Health, Hong Kong Special Administrative Region, People's Republic of China.
Ivan F LoClinical Genetic Service, Department of Health, Hong Kong Special Administrative Region, People's Republic of China.
David MowatCentre for Clinical Genetics, Sydney Children's Hospital, Randwick Sydney, New South Wales, Australia; School of Women's and Children's Health, The University of New South Wales, Sydney, New South Wales, Australia.
Elizabeth K FiorinoDivision of Pediatric Pulmonary Medicine, Cohen Children's Medical Center-Northwell Health, New Hyde Park, New York.
Morris EdelmanDivision of Pediatric Pathology, Cohen Children's Medical Center-Northwell Health, New Hyde Park, New York.
Joyce FoxDivision of Medical Genetics, Cohen Children's Medical Center-Northwell Health, New Hyde Park, New York.
Denise A HayesDivision of Pediatric Cardiology, Cohen Children's Medical Center-Northwell Health, New Hyde Park, New York.
David WitteDivisions of Pathology, Cincinnati, Ohio.
Ashley ParrottHuman Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Edwina PopekDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
Przemyslaw SzafranskiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
David Y ZhangDepartment of Bioengineering, Rice University, Houston, Texas. Electronic address: dyz1@rice.edu.
Pawel StankiewiczDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas. Electronic address: pawels@bcm.edu.

Funding

Highly multiplexed and mutation-sensitive quantitative PCR for cancer diagnosticsR01CA203964 · NCI · RICE UNIVERSITY · PI ZHANG, DAVID YU · 2016 to 2020
$3.0M
Unrecognized scale and clinical relevance of somatic mosaicismR01HD087292 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI STANKIEWICZ, PAWEL · 2017 to 2021
$2.5M
Epigenomic dysfunction at 16q24.1 vascular defects and perinatal consequencesR01HL137203 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI STANKIEWICZ, PAWEL · 2017 to 2020
$2.0M
NCI NIH HHS R01 CA203964NHLBI NIH HHS R01 HL137203NICHD NIH HHS R01 HD087292
6 · The paper itself

Abstract

Detection of low-level somatic mosaicism [alternate allele fraction (AAF) ≤ 10%] in parents of affected individuals with the apparent de novo pathogenic variants enables more accurate estimate of recurrence risk. To date, only a few systematic analyses of low-level parental somatic mosaicism have been performed. Herein, highly sensitive blocker displacement amplification, droplet digital PCR, quantitative PCR, long-range PCR, and array comparative genomic hybridization were applied in families with alveolar capillary dysplasia with misalignment of pulmonary veins. We screened 18 unrelated families with the FOXF1 variant previously determined to be apparent de novo (n = 14), of unknown parental origin (n = 1), or inherited from a parent suspected to be somatic and/or germline mosaic (n = 3). We identified four (22%) families with FOXF1 parental somatic mosaic single-nucleotide variants (n = 3) and copy number variant deletion (n = 1) detected in parental blood samples and an AAF ranging between 0.03% and 19%. In one family, mosaic allele ratio in tissues originating from three germ layers ranged between <0.03% and 0.65%. Because the ratio of parental somatic mosaicism have significant implications for the recurrence risk, this study further implies the importance of a systematic screening of parental samples for low-level and very-low-level (AAF ≤ 1%) somatic mosaicism using methods that are more sensitive than those routinely applied in diagnostics.

Indexed as

MosaicismAllelesAmino Acid SubstitutionDNA Copy Number VariationsDNA Mutational AnalysisFemaleForkhead Transcription FactorsGenotypeHumansMalePedigreePersistent Fetal Circulation SyndromePolymorphism, Single NucleotidePulmonary AlveoliPulmonary VeinsReal-Time Polymerase Chain ReactionForkhead Transcription FactorsFOXF1 protein, human

Identifiers

PMID32036090
PMCPMC7193866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.